Heaven-sent Blood Cancer Society

We provide information on children blood cancers from a layman's perspective

Our aim is to help fight against Leukemia and Lymphoma in Papua New Guinea. Team up with us to save lives.

Heaven-sent Blood Cancer Society's cover photo

Heaven-sent Blood Cancer Society's cover photo

Heaven-sent Blood Cancer Society's cover photo

[10/07/16]   If you want to better yourself, better your fellow being. If you want to feel the richness and warmth of unfailing love, give it. If you want to make a difference and leave your world a better place, let others know how important they are as you put their needs above yours.

[10/03/16]   If you shift your focus from yourself to others, extend your concern to others, and cultivate the thought of caring for the well being of others, then this will have the immediate effect of opening up your life and helping you to reach out.

[10/03/16]   WHAT IS BLOOD CANCER?

The researchers simplest definition of hematological (blood) cancers is that they are cancers which arise from a single blood cell. Since all blood cells are produced by a process called hematopoiesis (greek word for blood & formation), cancers such as leukemias, lymphomas, and myelomas are often referred to as blood cancers. The cancer type usually refers to the organ or the specific type of cell where cancer originates. To distinguish blood cancer from other forms of cancers, they are sometimes referred to as “liquid tumors” since they typically do not form lumps or masses (“tumors”). In contrast, cancers arising from all other cells, which typically form masses, are called “solid tumors.”

[10/02/16]   Most people are like you and me, or the people across the street or around the world from you and me. Just like you and me, their hearts tell them that somewhere, somehow, they can make a positive difference in the world (William Baker).

Heaven-sent Blood Cancer Society

According to Manuel (2016) Childhood acute leukemias are one of the main causes of death in children aged 1 to 14 years in some countries; and unfortunately, we have been unable to prevent it. Certainly, a good parcel of it is due to the poor understanding about its etiology.

Heaven-sent Blood Cancer Society

According to Manuel (2016) Childhood acute leukemias are one of the main causes of death in children aged 1 to 14 years in some countries; and unfortunately, we have been unable to prevent it. Certainly, a good parcel of it is due to the poor understanding about its etiology.

[10/01/16]   According to Manuel (2016) Childhood acute leukemias are one of the main causes of death in children aged 1 to 14 years in some countries; and unfortunately, we have been unable to prevent it. Certainly, a good parcel of it is due to the poor understanding about its etiology.

Heaven-sent Blood Cancer Society

According to Price (1983) there has been dramatic improvement in the survival of children with acute lymphoblastic leukemia. At the present time, over 50% of children with this disease will be alive and free of their disease at least 5 years from the time of their initial diagnosis. Although a number of factors have contributed to this improvement, perhaps none has been as important as the institution of central nervous system preventive therapy (eNS prophylaxis). However, despite the efficacy of eNS prophylaxis, the prevention and treatment of central nervous system leukemia continues to pose a formidable clinical challenge to the pediatric oncologist. Although successful in most cases, eNS preventive therapy remains ineffective for a small but significant subset of patients at high risk for developing eNS disease. Moreover, it has become increasingly evident that some methods of eNS preventive therapy are associated with long-term, adverse eNS sequelae. Thus, considerable controversy exists regarding the optimal method of eNS prophylaxis. Treatment of the patient who develops overt meningeal leukemia has not been as successful and continues to pose a major clinical challenge. Despite the ability of intrathecal chemotherapy and/or radiation therapy to induce eNS remission, most patients suffer subsequent relapse and ultimate survival is usually signifi­ cantly compromised. It is evident that newer approaches to treatment for this patient group must be identified before major improvement for this patient group is likely to occur.

[10/01/16]   According to Price (1983) there has been dramatic improvement in the survival of children with acute lymphoblastic leukemia. At the present time, over 50% of children with this disease will be alive and free of their disease at least 5 years from the time of their initial diagnosis. Although a number of factors have contributed to this improvement, perhaps none has been as important as the institution of central nervous system preventive therapy (eNS prophylaxis). However, despite the efficacy of eNS prophylaxis, the prevention and treatment of central nervous system leukemia continues to pose a formidable clinical challenge to the pediatric oncologist. Although successful in most cases, eNS preventive therapy remains ineffective for a small but significant subset of patients at high risk for developing eNS disease. Moreover, it has become increasingly evident that some methods of eNS preventive therapy are associated with long-term, adverse eNS sequelae. Thus, considerable controversy exists regarding the optimal method of eNS prophylaxis. Treatment of the patient who develops overt meningeal leukemia has not been as successful and continues to pose a major clinical challenge. Despite the ability of intrathecal chemotherapy and/or radiation therapy to induce eNS remission, most patients suffer subsequent relapse and ultimate survival is usually signifi­ cantly compromised. It is evident that newer approaches to treatment for this patient group must be identified before major improvement for this patient group is likely to occur.

Heaven-sent Blood Cancer Society

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course. While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid advances in the diagnosis, prognosis and treatment of CLL are rooted in an in-depth understanding of the basic and translational biology of CLL.

[09/30/16]   Literature based studies shows that the exciting new "biologic" therapies for treating leukemia are appearing so rapidly that clinicians often find it difficult to make informed decisions about their use when making patient treatment decisions. Here the busy physician will find in one convenient place crucial information on the uses and limitations of the major biologic therapies for leukemia, the different biologic strategies for its treatment, the management of patients being treated with such biologic agents, and the current and future role of emerging biologic agents.

[09/30/16]   Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course. While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid advances in the diagnosis, prognosis and treatment of CLL are rooted in an in-depth understanding of the basic and translational biology of CLL.

[09/30/16]   Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as the population ages.

Heaven-sent Blood Cancer Society's cover photo

Heaven-sent Blood Cancer Society

Want your business to be the top-listed Clinic in Port Moresby?

Click here to claim your Sponsored Listing.

Location

Category

Telephone

Address


Funky Town Taurama
Port Moresby
111
Other Doctors in Port Moresby (show all)
RMDL RMDL
PO Box 135 Boroko,NCD
Port Moresby

We provide dental services.We specialise in extractions,fillings,false teeth,tooth whitening,wiring etc..........!!

Dr. Aamir Siddiqui Dr. Aamir Siddiqui
Vayodha Hospital, P.O. Box No. 992, Balkhu Chowk
Port Moresby

Critical Care Intensivist

Hospital Medical Supply -PNGWide Hospital Medical Supply -PNGWide
Lot 14, Section 20, 3 Mile,
Port Moresby, NCD

We supply Medical Supplies throughout PNG & Pacific. Nothing is Too Small, Too Big, or Too Far Away. Contact us or email at [email protected]

Family Day Clinic & Practical Lifestyle Centre Family Day Clinic & Practical Lifestyle Centre
PO Box 213 Konedobu
Port Moresby

Family Day Clinic is exclusively a Primary Health Care and Practical Lifestyle Centre Facility, serving our communities